CINECA IRIS Institutional Research Information System

BONINO, FERRUCCIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.295
AS - Asia 12.414
EU - Europa 7.683
SA - Sud America 1.619
AF - Africa 212
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 9
Totale 46.244
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.546
CN - Cina 4.001
SG - Singapore 3.657
IT - Italia 2.045
HK - Hong Kong 2.033
BR - Brasile 1.369
SE - Svezia 1.181
VN - Vietnam 899
BG - Bulgaria 896
KR - Corea 759
UA - Ucraina 673
CA - Canada 632
FR - Francia 610
DE - Germania 568
FI - Finlandia 431
RU - Federazione Russa 388
GB - Regno Unito 382
TR - Turchia 362
CH - Svizzera 267
IN - India 177
AR - Argentina 100
BD - Bangladesh 98
JP - Giappone 89
MX - Messico 54
ID - Indonesia 49
AT - Austria 48
IQ - Iraq 48
ZA - Sudafrica 43
PK - Pakistan 41
EC - Ecuador 38
BE - Belgio 35
CI - Costa d'Avorio 33
SA - Arabia Saudita 31
EG - Egitto 29
UZ - Uzbekistan 24
CO - Colombia 23
ES - Italia 23
MA - Marocco 23
NL - Olanda 23
VE - Venezuela 23
KE - Kenya 20
CL - Cile 19
MY - Malesia 17
PH - Filippine 17
PY - Paraguay 15
BJ - Benin 14
CZ - Repubblica Ceca 14
HU - Ungheria 14
IE - Irlanda 14
NP - Nepal 14
PL - Polonia 14
AE - Emirati Arabi Uniti 13
RO - Romania 13
TT - Trinidad e Tobago 12
PE - Perù 11
UY - Uruguay 11
TN - Tunisia 10
CR - Costa Rica 9
DZ - Algeria 9
AL - Albania 8
IR - Iran 8
SN - Senegal 8
TW - Taiwan 8
BO - Bolivia 7
DO - Repubblica Dominicana 7
JM - Giamaica 7
JO - Giordania 7
OM - Oman 7
RS - Serbia 7
AU - Australia 6
GR - Grecia 6
IL - Israele 6
KZ - Kazakistan 6
NG - Nigeria 6
PT - Portogallo 6
XK - ???statistics.table.value.countryCode.XK??? 6
AZ - Azerbaigian 5
HN - Honduras 5
NZ - Nuova Zelanda 5
PA - Panama 5
TH - Thailandia 5
ET - Etiopia 4
GT - Guatemala 4
DK - Danimarca 3
GE - Georgia 3
GY - Guiana 3
KG - Kirghizistan 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
LB - Libano 3
QA - Qatar 3
SV - El Salvador 3
AM - Armenia 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BN - Brunei Darussalam 2
BZ - Belize 2
CY - Cipro 2
EU - Europa 2
Totale 46.203
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.810
Ashburn 2.381
Fairfield 2.353
Singapore 2.047
Hong Kong 2.014
Ann Arbor 1.828
Houston 1.720
Chandler 1.083
San Jose 1.058
Hefei 1.036
Milan 990
Seattle 953
Sofia 895
Jacksonville 879
Dallas 815
Wilmington 775
Seoul 757
Cambridge 726
Santa Clara 694
Shanghai 650
Beijing 604
New York 575
Ottawa 551
Boardman 377
Princeton 358
Lawrence 353
Medford 316
Lauterbourg 310
Des Moines 303
Nanjing 270
Bern 253
Los Angeles 223
Ho Chi Minh City 192
Buffalo 170
Dearborn 169
Istanbul 166
Izmir 160
Frankfurt am Main 157
Jüchen 155
Dong Ket 136
Hanoi 130
Nanchang 121
San Diego 119
Redondo Beach 108
São Paulo 98
Helsinki 92
Council Bluffs 85
Kunming 84
Tokyo 70
Changsha 65
Rome 65
Shenyang 63
Hebei 57
Ogden 52
Redwood City 48
Rio de Janeiro 45
Munich 42
Tianjin 42
Belo Horizonte 40
Boulder 40
Vienna 40
Chicago 39
Jiaxing 37
Pune 37
London 36
Lancaster 34
Abidjan 33
Pisa 33
Brussels 31
Norwalk 31
The Dalles 31
Florence 30
Columbus 29
Da Nang 29
Turku 28
Washington 28
Brasília 27
Jinan 25
Toronto 24
Tashkent 23
Dhaka 22
Falls Church 22
Guangzhou 22
Nuremberg 22
Paris 22
Curitiba 21
Hangzhou 21
San Francisco 21
Baghdad 20
Fuzhou 20
Orem 20
Phoenix 19
Verona 19
Haiphong 18
Orange 18
Campinas 16
Atlanta 15
Cairo 15
Fortaleza 15
Johannesburg 15
Totale 34.736
Salva come PNG Salva come JPEG
Nome #
Active HBV replication in HBsAg carriers with chronic Delta infection 247
Animal model for liver cell banking from non-heart beating donors after prolongedischaemia time 246
Delta hepatitis in inapparent carriers of hepatitis B surface antigen 239
A histological study of hepatitis delta virus liver disease 232
Prognostic significance of in-vitro complement fixation in liver biopsy specimens from patients with acute viral hepatitis type B 229
Diagnosis of Budd-Chiari syndrome by pulsed Doppler ultrasound 225
Serum markers of hepatitis B virus replication, liver histology and intrahepatic expression of hepatitis B core antigen 222
Chronic Hepatitis in Carriers of Hepatitis B Surface Antigen, with Intrahepatic Expression of the Delta Antigen 220
Chronic hepatitis in HBsAg carriers with serum HBV-DNA and Anti-HBe 220
Normal lymphocyte interferon production in adult HBsAg-positive chronic active liver disease 219
Hepatitis B virus replication and clinical outcome in carriers of HBsAg.Perspectives of treatment with DNA inhibitors 218
Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen 218
Levamisole and chronic delta hepatitis 210
Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis 205
Delta hepatitis agent: structural and antigenic properties of the delta-associated particle 204
REPLICATING AND VIRION SECRETING HEPATITIS B MUTANT VIRUS UNABLE TO PRODUCE PRES2 PROTEIN 204
Hepatitis B virus replication modulates pathogenesis of hepatitis D virus in chronic hepatitis D 204
Emergence of hepatitis B virus quasispecies with lower susceptibility to nucleos(t)ide analogues during lamivudine treatment 204
A new hepatitis B virus strain in patients with severe anti-HBe positive chronic hepatitis B 202
Sequence variation in hepatitis C viral isolates 202
The importance of hepatitis B viral DNA in serum and liver 200
A precore-defective mutant of hepatitis B virus associated with e antigen-negative chronic liver disease 200
Experimental transmission of the delta agent to chimpanzees 199
Role of IgM antibody to hepatitis B core antigen in the diagnosis of hepatitis B exacerbations 196
T-lymphocyte response to hepatitis C virus in different clinical courses of infection 196
A multiphase model of th dynamics of HBV infection in HBeAg-negative patients during pegylated interferon-alfa2a, lamivudine and combination therapy 195
Complexes between HBsAg and IgM in serum of patients with acute hepatitis 194
Hepatitis G virus RNA in the serum of patients with elevated gamma glutamyl transpeptidase and alkaline phosphatase: a specific liver disease? 194
Familiar clustering and spreading of hepatitis delta virus infection 193
Hepatitis delta virus, a model of liver cell pathology 192
The natural history of chronic delta hepatitis 188
Superimposed Hepatitis and the Effect on Viral replication in Chronic Hepatitis B 188
Expression of estrogen receptor mRNA in tumorous and non-tumorous liver tissue as detected by in situ hybridization 188
Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases 188
Liver stiffness, a non-invasive marker of liver disease in the HBV carrier 188
Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated with hepatitis B virus in liver and in serum of HBsAg carriers 188
Chronic hepatitis B e antigen (HBeAg) negative, anti-HBe positive hepatitis B: an overview 186
Steato-Score: Non-Invasive Quantitative Assessment of Liver Fat by Ultrasound Imaging 185
Digital liver biopsy: Bio-imaging of fatty liver for translational and clinical research 185
Trasmission of the hepatitis B virus-associated delta agent to the eastern woodchuck 184
Precore mutant hepatitis B virus and outcome of chronic infection and hepatitis in hepatitis B e antigen-positive children 184
High prevalence of autoimmune phenomena in hepatitis C virus antibody positive patients with lymphoproliferative and connective tissue disorders 184
Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers 183
The e antigen and antibody in the serum of patients with HBsAg-positive liver disease and in asymptomatic carriers 182
Quantitative analysis of IgM anti-HBc in chronic hepatitis B patients using a new "gray-zone" for the evaluation of "borderline" values 182
Properties of delta-associated ribonucleic acid 181
Effects of a bicarbonate-alkaline mineral water on gastric functions and functional dyspepsia: a preclinical and clinical study 181
Severe liver injury possibly due to verapamil 180
AN ESSAY FOR CIRCULATING ANTIBODIES TO A MAJOR ETIOLOGIC VIRUS OF HUMAN NON-A, NON-B HEPATITIS 180
Detection of intrahepatic replication of hepatitis C virus RNA by in situ hybridization and comparison with histopathology 180
Variants of hepatitis B virus 180
Antibodies against the human pancreas in acute and chronic liver disease 179
Hepatitis B virus heterogeneity, one of many factors influencing the severity of hepatitis B 179
Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study 179
Decompensated chronic heart failure: increased liver stiffness measured by means of transient elastography. 179
Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein 178
Hepatitis B virus unable to secrete e antigen 177
Possible immunopathogenesis for fibrosing cholestatic hepatitis 177
Hepatitis C virus infection in type II essential mixed cryoglobulinemias 177
Adenine arabinoside monophosphate coupled to lactosaminated human albumin administered for 4 weeks in patients with chronic type B hepatitis decreased viremia without producing significant side effects 177
Inhibition of hepatitis B virus replication by vidarabine monophosphate conjugated with lactosaminated serum albumin 176
Detection of HBV-DNA by in-situ hybridization using a biotin- labeled probe 174
Quantitative detection of hepatitis C virus RNA in the serum of patients with chronic hepatitis C treated with interferon: a pilot study 174
Multicenter evaluation of the elecsys hepatitis B surface antigen quantitative assay 174
Delta agent (type D) hepatitis 174
Software and expert system for the management of chronic hepatitis B 173
Total Hepatitis B Core Antigen Antibody, a Quantitative Non-Invasive Marker of Hepatitis B Virus Induced Liver Disease 173
Rapidly progressive HBsAg-positive hepatitis in Italy. The role of hepatitis delta virus infection 172
Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C 172
Quantitative analysis of wild-type and HBeAg minus hepatitis B viruses by a sequence-dependent primer extension assay 172
Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B 172
Chronic Delta Hepatitis 171
Rapidly progressive HBsAg hepatitis in Italy: a syndrome of Delta hepatitis virus superinfection 171
Characterization of hepatitis delta antigen gene of a highly pathogenic strain of hepatitis delta virus 171
Impact of interferon-alpha therapy on the development of hepatocellular carcinoma in patients with liver cirrhosis: results of an international survey 170
Hepatitis B virus surface antigen levels: a guide to sustained response to Peginterferon alfa-2a in HBeAg-negative chronic hepatitis B 169
A dynamic analysis of IgM anti-HCV helps to distinguish hepatitis C from acute rejection in liver transplant patients 168
Validation and comparison of different PCR-based methods for detection of Hepatitis B virus precore region mutants 168
Viral load 1 week after liver transplantation, donor age and rejections correlate with the outcome of recurrent hepatitis C 168
Reduced expression of the melanocortin-1 receptor in human liver during brain death 166
New immunoassays for total, IgA and IgM antibodies against hepatitis E virus: Prevalence in Italian blood donors and patients with chronic liver or kidney diseases 166
Early and accurate prediction of Peg-IFNs/ribavirin therapy outcome in the individual patient with chronic hepatitis C by modeling the dynamics of the infected cells 166
Incidence and significance of different types of connective tissue antibodies in adult and pediatric gastroenterological disorders 165
Problems in diagnosing viral hepatitis 165
IgM antibody against measles virus in patients with inflammatory bowel disease: a marker of virus-related disease? 165
Treatment of chronic hepatitis B: from research to clinical practice via the consensus conferences 165
Introduction to 'Hepatitis B virus heterogeneity--a means to personalized care' 165
Subthreshold mania as predictor of depression during interferon treatment in HCV+ patients without current or lifetime psychiatric disorders 165
Mitochondrial antibody in Italy: diagnostic value in primary biliary cirrhosis 164
Uridine diphosphate glucoronosyl transferases, candidate antigens of liver-kidney microsomal antibodies in hepatitis delta virus-infected patients 164
Quantification of serum markers of hepatitis B (HBV) and Delta virus (HDV) infections in patients with chronic HDV infection. 164
Personalized Therapy in chronic viral hepatitis 163
Role of hepatitis delta virus infection in hepatocellular carcinoma 162
Comparable function of plasmacytoid and monocyte-derived dendritic cells in chronic hepatitis C patients and healthy donors 162
Patterns of natural killer cell function activation in response to interferon in chronic HBsAG positive hepatitis: relationship with the state of viral infection and with the early clinical response 161
Increasing serum levels of IgM anti-HCV are diagnostic of recurrent hepatitis C in liver transplant patients with ALT flares 160
Increasing serum levels of IgM anti-HCV are diagnostic of recurrent hepatitis C in liver transplant patients with ALT flares 159
The colostomized patient:a psycological and psycopathological investigation 158
Does HBeAg minus HBV modify the course of HDV superinfection? 157
Subthreshold mania as predictor of depression during interferon treatment in HCV+ patients without current or lifetime psychiatric disorders 157
Totale 18.477
Salva come PNG Salva come JPEG
Categoria #
all - tutte 124.609
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 124.609
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021439 0 0 0 0 0 0 0 0 0 0 0 439
2021/20223.597 98 230 46 255 671 543 100 168 200 152 106 1.028
2022/20233.049 502 266 190 248 377 489 34 236 474 20 178 35
2023/20243.450 622 384 487 223 489 645 50 108 73 30 36 303
2024/20258.789 13 388 58 499 447 634 700 505 893 1.299 1.344 2.009
2025/20269.834 621 1.778 1.356 1.008 701 1.009 1.446 393 407 731 298 86
Totale 46.540